久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

Global EditionASIA 中文雙語Fran?ais
World
Home / World / China-Europe

'Right steps' point to a healthier China

By Wang Mingjie | China Daily Europe | Updated: 2017-12-10 20:53
Share
Share - WeChat

Country will benefit greatly from medical research and policy changes, says executive of pharmaceutical giant

Dieter Weinand, president of the pharmaceuticals division and a member of the management board of Bayer AG, speaks at Annual Pharmaceuticals Media Day in Berlin on Dec 1. Provided to China Daily

China's emphasis on innovation in recent years has led to more opportunities for global clinical development and research programs to be conducted in the country, something that has benefited its people, says a leading executive at a top German pharmaceutical company.

Dieter Weinand, president of Bayer AG's pharmaceuticals division and a member of the company's management board, said: "The Chinese government is taking the right steps in assuring that new medicines can be approved in China faster, by allowing full studies conducted in other countries to be utilized and updated in China."

He said the company used to have to set up separate programs for China, which meant it took much longer for new drugs to reach Chinese customers.

Speaking at the Annual Pharmaceuticals Media Day in Berlin, Weinand said: "The ability to include Chinese patients now in clinical research and development in a global program will automatically bring more clinical research into China."

He said the company welcomes the Chinese government's recent reforms, which "make it much easier for us to get drugs to the market faster in China". Weinand said the move also adds an incentive for Bayer to conduct more comprehensive and advanced clinical research at its China Innovation Center in Beijing, which until now has only hosted early-stage research.

Bayer's links with China go back a long way: The business established a presence in the country in 1882. As a leading global company in the fields of healthcare and agriculture, its classic medicine - aspirin - has a history going back 120 years.

Today, China is Bayer's largest single market in Asia, accounting for sales of more than 2.67 billion euros ($3.18 billion; £2.36 billion) in 2016. Its Chinese workforce numbers more than 10,000.

Weinand said the company's vision in relation to China is in line with the government's policy of improving the lives of Chinese people. He believes "a healthier population is more productive and a more productive population results in better economic status, and therefore a better life.

"We have a program in place with the Chinese government to support the Go West initiative, where we provide unrestricted grants and efforts for the Chinese government to bring better healthcare to the more western provinces in China. Our support has resulted in the training of physicians, not only in medical capabilities but also in administration of healthcare system and hospitals."

Thousands of physicians are being trained. The company recently signed a new agreement for the next five years, in which it commits to continue to support the effort to change the imbalance in medical care between the rural west and urban east.

Weinand said this aim aligns with the Chinese government's mission to tackle the current principal contradiction faced by the Chinese people, which is the tension between "unbalanced and inadequate development and the people's ever-growing needs for a better life". It was outlined in October by President Xi Jinping at the 19th National Congress of the Communist Party of China.

Weinand said China is on the brink of an innovation revolution in medicine, not only in treatment and clinical medicine but also in terms of the number of scientists at work.

"I recently went into an organ transplant center in Shanghai and was shocked at the success rate they have, as well as the capabilities. Even the world's leading experts are going to visit this transplant center in China to learn," he said.

Weinand applauded the consolidation that has happened, and continues to happen, in China among thousands of small, generic companies that used to co-exist and carry out their own small-scale research. He said these were not cost-efficient and their research was not always of high quality before consolidation.

"When you have a handful of major generic companies that propose high-quality generics for the Chinese market, there will no longer be any difference between the original and the generic. That allows you to treat patients inexpensively, so money can be reinvested into innovative pharmaceuticals, leading to high-quality generics at a low price for everybody, rather than paying a higher price for the originator of the patent. That innovation drive is going to be good for Chinese patients," he said.

Moving forward, Weinand said he would welcome continued progress in matters including regulatory reform, innovation, value pricing and national drug listing.

"I would like to see more frequent additions (of medicine) to the national reimbursement list. There were years when nothing was added. That is not helpful to Chinese patients, nor to innovation," he said, adding value-based evaluations of medical products should be introduced.

Last year, Bayer increased its global investment in research and development by 9.2 percent, to nearly 4.7 billion euros. Around 60 percent of that total (nearly 2.8 billion euros) was assigned to the development of new pharmaceuticals, with a focus on therapeutic areas of cardiology, oncology and women's healthcare.

In 2017, the company plans to further increase its overall research and development spending to about 4.8 billion euros.

As an innovative player in women's healthcare, Bayer has been pioneering the promotion of the estrogen balance management concept among Chinese women. Under the Post Abortion Care Project, the company is also making long-term efforts to educate women about effective contraception and reduce the harm caused by repeated abortions. To date, the project has benefited more than 6 million women.

Noting that China is Bayer's second-largest market globally, Weinand said the company is determined to further expand its involvement in the country, to improve the its healthcare and medical services and help in offering better lives to Chinese patients.

wangmingjie@mail.chinadailyuk.com

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    先锋影音男人资源| 噜噜噜久久亚洲精品国产品麻豆| 天天做天天躁天天躁| 波多野结衣之无限发射| 亚洲精品久久久中文字幕| 日本道在线视频| 一区二区三区免费播放| 黄色成人在线免费观看| 冲田杏梨av在线| 97视频久久久| 超碰中文字幕在线观看| 国产第一页视频| 成人在线视频一区二区三区| 亚洲高清免费在线观看| 国产黄视频在线| 国产91在线亚洲| 黄色aaaaaa| 日本激情视频在线| www.99热这里只有精品| 亚洲一区 在线播放| 天天干天天综合| 不卡影院一区二区| 成人在线免费观看av| 国产 欧美 日韩 一区| 91插插插影院| 亚洲欧洲日本精品| 亚洲视频在线观看一区二区三区| 成年人午夜免费视频| 一二三在线视频| 黄频视频在线观看| 911福利视频| 福利片一区二区三区| 美女网站免费观看视频 | 亚洲爆乳无码专区| 成人黄色大片网站| 日韩免费在线观看av| 看全色黄大色大片| 国产a级片免费看| 亚洲一区二区偷拍| 做a视频在线观看| 手机版av在线| 超碰成人在线播放| 午夜不卡福利视频| 捷克做爰xxxⅹ性视频| 亚洲男人天堂av在线| 美女在线视频一区二区| 国产一区二区在线免费播放| 毛葺葺老太做受视频| 超碰在线人人爱| 色噜噜狠狠永久免费| 奇米视频888| 在线播放免费视频| 天天干天天操天天干天天操| 亚欧美一区二区三区| 色一情一乱一乱一区91| 97在线免费视频观看| www.亚洲成人网| 久激情内射婷内射蜜桃| 亚洲欧洲日产国码无码久久99 | 中文字幕 91| 手机在线视频一区| avove在线观看| 国产精品va在线观看无码| www污在线观看| 无码人妻精品一区二区三区在线| 日韩精品一区二区三区色欲av| 爱情岛论坛vip永久入口| mm131亚洲精品| 中国一级大黄大黄大色毛片| 人人妻人人澡人人爽欧美一区双| 国产精品专区在线| 别急慢慢来1978如如2| 中文字幕精品一区二区三区在线| 99精品视频国产| 久久亚洲a v| 国产综合免费视频| 久热在线视频观看| 人妻互换免费中文字幕| 欧美老熟妇喷水| 成年网站免费在线观看| 台湾无码一区二区| 成人免费观看毛片| 国产精品探花在线播放| 久久99久久99精品| 国产性生交xxxxx免费| 日本中文字幕在线不卡| 隔壁人妻偷人bd中字| 中文字幕第21页| 九九久久九九久久| 欧美亚洲国产成人| 亚洲av无日韩毛片久久| 欧美激情视频免费看| 别急慢慢来1978如如2| 国产成人免费高清视频| 免费黄色日本网站| 天堂av免费看| 欧在线一二三四区| 成人区一区二区| 欧美婷婷精品激情| 日本免费a视频| 第四色婷婷基地| 青青青青草视频| www.桃色.com| 日本一极黄色片| 国产精品久久久久久久乖乖| 黄色国产小视频| 日韩在线观看a| 午夜免费福利网站| 国产日韩成人内射视频| 国产91porn| 天天影视色综合| 97国产精东麻豆人妻电影| 美女黄色片网站| 亚洲少妇第一页| 国产精品国产亚洲精品看不卡| 日本人69视频| 欧在线一二三四区| 霍思燕三级露全乳照| 日韩不卡的av| 欧美大尺度做爰床戏| 欧美一区二区中文字幕| 色中文字幕在线观看| 一区二区三区韩国| 男人日女人下面视频| 无码毛片aaa在线| www激情五月| 中文字幕av不卡在线| 女性隐私黄www网站视频| 亚洲国产精品无码观看久久| 亚洲天堂网站在线| 五月激情婷婷在线| 欧美日韩怡红院| 北条麻妃在线一区| 国产 福利 在线| 男人插女人视频在线观看| 97人人模人人爽人人澡| 色天使在线观看| 亚洲精品久久久中文字幕| 超碰网在线观看| 黄色国产精品视频| 欧美爱爱视频免费看| 女人帮男人橹视频播放| 日本福利视频导航| 亚洲在线观看网站| 色乱码一区二区三区在线| 国产福利影院在线观看| 欧美牲交a欧美牲交aⅴ免费下载| 久久综合九色综合88i| 99在线免费视频观看| 视色,视色影院,视色影库,视色网 日韩精品福利片午夜免费观看 | 一区二区免费av| 自拍偷拍 国产| 亚洲天堂av线| 老熟妇仑乱视频一区二区| 中文字幕日本最新乱码视频| 成人在线免费观看av| 免费在线a视频| 成人黄色片视频| 超碰97人人射妻| 亚洲狼人综合干| 99热一区二区| 午夜视频在线观| 二级片在线观看| 毛片av在线播放| youjizz.com在线观看| 日韩精品一区二区三区四| 僵尸世界大战2 在线播放| 成人免费aaa| 人妻内射一区二区在线视频| 欧美自拍小视频| 久久综合在线观看| 成人毛片100部免费看| 妞干网视频在线观看| 欧美爱爱视频免费看| 欧美激情国产精品日韩| 亚洲一级片免费| 亚洲热在线视频| 日本人体一区二区| 日本成年人网址| 污视频网站观看| 最近免费观看高清韩国日本大全| 日本五级黄色片| 日韩精品一区二区三区色欲av| 手机在线成人免费视频| 少妇高潮流白浆| 黄色网页免费在线观看| 日韩无套无码精品| 吴梦梦av在线| 免费超爽大片黄| 国产激情在线观看视频| 婷婷激情5月天| 超碰成人免费在线| 乌克兰美女av| 热久久最新地址| 日韩黄色片视频| 视频区 图片区 小说区| 免费在线看黄色片| 99热这里只有精品在线播放| 三上悠亚免费在线观看| 波多野结衣家庭教师在线|